NO974206D0 - 17-difluormethylen-östratriener - Google Patents

17-difluormethylen-östratriener

Info

Publication number
NO974206D0
NO974206D0 NO974206A NO974206A NO974206D0 NO 974206 D0 NO974206 D0 NO 974206D0 NO 974206 A NO974206 A NO 974206A NO 974206 A NO974206 A NO 974206A NO 974206 D0 NO974206 D0 NO 974206D0
Authority
NO
Norway
Prior art keywords
hydrogen atom
beta
alpha
estratrienes
difluoromethyl
Prior art date
Application number
NO974206A
Other languages
English (en)
Other versions
NO974206L (no
NO308306B1 (no
Inventor
Rolf Bohlmann
Gabor Rubanyl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974206D0 publication Critical patent/NO974206D0/no
Publication of NO974206L publication Critical patent/NO974206L/no
Publication of NO308306B1 publication Critical patent/NO308306B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Exhaust-Gas Circulating Devices (AREA)
  • Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
  • Saccharide Compounds (AREA)
  • Vehicle Body Suspensions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ceramic Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO974206A 1995-03-13 1997-09-12 17-difluormethylen-østratriener NO308306B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19509729A DE19509729A1 (de) 1995-03-13 1995-03-13 17-Difluormethylen-Estratriene
PCT/EP1996/001069 WO1996028462A1 (de) 1995-03-13 1996-03-13 17-difluormethylen-estratriene

Publications (3)

Publication Number Publication Date
NO974206D0 true NO974206D0 (no) 1997-09-12
NO974206L NO974206L (no) 1997-11-13
NO308306B1 NO308306B1 (no) 2000-08-28

Family

ID=7756963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974206A NO308306B1 (no) 1995-03-13 1997-09-12 17-difluormethylen-østratriener

Country Status (21)

Country Link
US (2) US6018062A (no)
EP (1) EP0815120B1 (no)
JP (1) JPH11501644A (no)
KR (1) KR19980703002A (no)
AT (1) ATE199159T1 (no)
AU (1) AU693335B2 (no)
BR (1) BR9612787A (no)
CA (1) CA2215201A1 (no)
CZ (1) CZ281097A3 (no)
DE (2) DE19509729A1 (no)
HU (1) HUP9801846A3 (no)
IL (1) IL117497A (no)
IS (1) IS4556A (no)
NO (1) NO308306B1 (no)
PL (1) PL322199A1 (no)
RU (1) RU2155770C2 (no)
SI (1) SI9620030A (no)
SK (1) SK121697A3 (no)
TR (1) TR199700950T1 (no)
WO (1) WO1996028462A1 (no)
ZA (1) ZA962037B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
CA2534497A1 (en) * 2003-08-11 2005-02-17 Industria Chimica Reggiana I.C.R. S.P.A. Chemical composition and method of polymerisation thereof for use on vehicle bodywork repair
AU2005259499A1 (en) * 2004-06-29 2006-01-12 Jado Technologies Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5783571A (en) * 1991-01-07 1998-07-21 Pherin Corporation Method of altering hypothalamic function by nasal administration of estrene steroids
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)

Also Published As

Publication number Publication date
AU693335B2 (en) 1998-06-25
DE59606435D1 (de) 2001-03-22
RU2155770C2 (ru) 2000-09-10
IL117497A (en) 1999-12-22
KR19980703002A (ko) 1998-09-05
AU5107896A (en) 1996-10-02
PL322199A1 (en) 1998-01-19
DE19509729A1 (de) 1996-09-19
EP0815120B1 (de) 2001-02-14
NO974206L (no) 1997-11-13
SK121697A3 (en) 1998-02-04
NO308306B1 (no) 2000-08-28
SI9620030A (sl) 1998-02-28
ZA962037B (en) 1996-09-25
HUP9801846A3 (en) 1999-03-01
CA2215201A1 (en) 1996-09-19
TR199700950T1 (xx) 1998-02-21
JPH11501644A (ja) 1999-02-09
ATE199159T1 (de) 2001-02-15
HUP9801846A2 (hu) 1998-12-28
IS4556A (is) 1997-09-08
MX9707006A (es) 1997-11-29
IL117497A0 (en) 1996-07-23
BR9612787A (pt) 1999-11-23
CZ281097A3 (cs) 1998-02-18
US6018062A (en) 2000-01-25
US6136800A (en) 2000-10-24
EP0815120A1 (de) 1998-01-07
WO1996028462A1 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
NL350077I1 (nl) Cyprosulfamide
TR199801399T2 (xx) Yeni 19-nor-pregnen t�revleri.
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ATE270817T1 (de) Fungizide
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
DE69716292D1 (de) Benzopyranderivate
TR200201102T2 (tr) Yeni oligosakkaritler, bunların hazırlanması ve bunları içeren ilaç bileşimleri
TR199701728T1 (xx) Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.
ATE338576T1 (de) Kosmetische zusammensetzungen
DK0934080T3 (da) 1,3-Bis-(N-lactamyl)propaner og deres farmaceutiske og kosmetiske anvendelse
DE59606435D1 (de) 17-difluormethylen-estratriene
DK0852580T3 (da) Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
TW350041B (en) Bis-depside tertiary alkyl ester derivatives and chemical positive photoresist material
TR199701298T1 (xx) Tetralinler.
TR199700802T2 (xx) Triazin t�revleri.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ES2090995T3 (es) Copolimeros de siloxano que contienen grupos viniloxi, su preparacion y utilizacion.
DK0788472T3 (da) Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater
ES2001102A6 (es) Un procedimiento para la preparacion de un derivado de indeno.
ES2061336T3 (es) 3-(2-cloro-4-(trifluorometil)fenoxi)-1-azetidincarboxamidas que tienen actividad anticonvulsiva.